Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 1630-1638

  Zhang, Qiu Yu ^a,b   Wu, Lin Qing ^a   Zhang, Tao ^a   Han, Yan Fei ^a   Lin, Xu ^b  

^a Guangdong Provincial Key Laboratory of New Drug Screening   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; ERK; Gastric cancer; HMGB1; MAPK; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GEFITINIB; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; AGER PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; HMGB1 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; TUMOR PROTEIN;

ARTICLE; AUTOPHAGY; BGC 823 CELL LINE; CANCER PATIENT; CANCER TISSUE; CARCINOMA CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GES 1 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MKN 28 CELL LINE; MKN 45 CELL LINE; MTT ASSAY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SGC 7901 CELL LINE; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOMA; STOMACH EPITHELIUM; TUMOR GROWTH; WESTERN BLOTTING; ADENOCARCINOMA; BLOOD; CHEMISTRY; DRUG EFFECTS; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; STOMACH TUMOR;

ADENOCARCINOMA; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL SURVIVAL; CYTOPLASM; ENZYME ACTIVATION; EXTRACELLULAR FLUID; HMGB1 PROTEIN; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM PROTEINS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84924891711     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3782     Document Type: Article

References (30)

1. Bao G, Qiao Q, Zhao H and He X: Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas. World J Surg Oncol 8: 52, 2010.
2. Chung HW, Lee SG, Kim H, et al: Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J Transl Med 7: 38, 2009.
3. Akaike H, Kono K, Sugai H, et al: Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res 27: 449-457, 2007.
4. Sims GP, Rowe DC, Rietdijk ST, Herbst R and Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367-388, 2010.
5. Kang R, Zhang Q, Zeh HJ III, Lotze MT and Tang D: HMGB1 in cancer: good, bad, or both? Clin Cancer Res 19: 4046-4057, 2013.
6. Bianchi ME and Beltrame M: Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep 1: 109-114, 2000.
7. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
8. Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
9. Tang D, Kang R, Cheh CW, et al: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29: 5299-5310, 2010.
10. Liu L, Yang M, Kang R, et al: HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 25: 23-31, 2011.
11. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
12. Tang D, Kang R, Livesey KM, et al: Endogenous HMGB1 regulates autophagy. J Cell Biol 190: 881-892, 2010.
13. Liu K, Huang J, Xie M, et al: MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy 10: 442-452, 2014.
14. Pusterla T, Németh J, Stein I, et al: Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. Hepatology 58: 363-373, 2013.
15. Davalos AR, Kawahara M, Malhotra GK, et al: p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol 201: 613-629, 2013.
16. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE and Thorburn A: Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 16: 175-183, 2009.
17. Smolarczyk R, Cicho? T, Matuszczak S, et al: The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. Arch Immunol Ther Exp (Warsz) 60: 391-399, 2012.
18. Taguchi A, Blood DC, del Toro G, et al: Blockade of RAGE?amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360, 2000.
19. Zhao M, Yang M, Yang L, et al: HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep 44: 601-606, 2011.
20. van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA and Griffioen AW: Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene 32: 363-374, 2013.
21. Volp K, Brezniceanu ML, Bosser S, et al: Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55: 234-242, 2006.
22. Cheng BQ, Jia CQ, Liu CT, et al: Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Dig Liver Dis 40: 446-452, 2008.
23. Zhan Z, Li Q, Wu P, et al: Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1. Autophagy 8: 109-121, 2012.
24. Brunelle JK, Ryan J, Yecies D, Opferman JT and Letai A: MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts. J Cell Biol 187: 429-442, 2009.
25. Kang R, Tang D, Lotze MT and Zeh HJ III: AGER/RAGEmediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy 8: 989-991, 2012.
26. Degenhardt K, Mathew R, Beaudoin B, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64, 2006.
27. Kang R, Livesey KM, Zeh HJ, Loze MT and Tang D: HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 6: 1209-1211, 2010.
28. Zhang J, Zhu JS, Zhou Z, Chen WX and Chen NW: Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep 27: 1511-1519, 2012.
29. Kang R, Tang D, Schapiro NE, et al: The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 33: 567-577, 2014.
30. Lin L, Zhong K, Sun Z, Wu G and Ding G: Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J Cancer Res Clin Oncol 138: 11-22, 2012.